|
Trade Name | Plasma Delipidation System (PDS-2™) |
Classification Name | plasma processing system for converting alpha to pre-beta high-density lipoprotein |
Generic Name | plasma processing system for converting alpha to pre-beta high-density lipoprotein |
Applicant |
HDL Therapeutics, Inc. |
601 21st street, suite 300 |
vero beach, FL 32960 |
|
HDE Number | H190001 |
Supplement Number | S003 |
Date Received | 09/13/2021 |
Decision Date | 12/05/2021 |
Product Code | |
Advisory Committee |
Gastroenterology |
Supplement Type | normal 75 day track |
Supplement Reason | postapproval study protocol |
Expedited Review Granted? | No |
Combination Product | No |
Approval Order Statement Approval of the human factors (hf) post-approval study (pas) protocol for the post-approval study (pas) referenced above. The hf pas protocol has been submitted to comply with the conditions of approval outlined in our approval order for h190001. |